Source: Annual Congress 2008 - Actual challenges in thoracic surgery
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
H. Rostad, A. Naalsund, T. E. Strand, S. Hummerfelt, T. Amundsen, S. L. Steinshamn (Oslo, Trondheim, Norway). Small cell lung cancer (SCLC) in Norway. A population-based study. Eur Respir J 2008; 32: Suppl. 52, 294

Member's Comments

No comment yet.

Related content which might interest you: European treatment guidelines: small cell lung cancer (SCLC) Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Management of small cell lung cancer in Norway Source: Eur Respir J 2003; 22: Suppl. 45, 65s Year: 2003 Small cell lung cancer in patients with elderly Source: Annual Congress 2007 - Therapy of lung cancer Year: 2007 Prospective population-based study on the survival of patients with lung cancer Source: Eur Respir J 2002; 19: 1087-1092 Year: 2002 TNM and survival in small cell lung cancer: results of a population-based study Source: Eur Respir J 2001; 18: Suppl. 33, 394s Year: 2001 Lung cancer Source: Respipedia Article Year: 2018 Challenges in the management of SCLC Source: ERS webinar 2021: Challenges in the management of SCLC Year: 2021 Small cell lung cancer Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 New cryobiopsy techniques influence the rate of diagnosis small cell lung cancer (SCLC) Source: Annual Congress 2010 - The role of endoscopy in the diagnosis of lung cancer Year: 2010 Pembrolizumab versus nivolumab as second and further line treatment in non-small cell lung cancer; a retrospective single-centre study Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology Year: 2020 Lung cancer: does age affect treatment strategy? Source: Eur Respir Mon; 2009: 43:306–326 Year: 2009 Cancer recurrence in surgically treated non small cell lung cancer (NSCLC) Source: Eur Respir J 2006; 28: Suppl. 50, 755s Year: 2006 CTLA-4, CD28, and ICOS gene polymorphisms in non-small cell lung cancer in a Polish population- case control study Source: Annual Congress 2010 - Epidemiology of lung cancer Year: 2010 Small cell lung cancer in never-smokers Source: Eur Respir J 2016; 47: 947-953 Year: 2016 Cyclooxygenase(COX)-2 is over-expressed in non small cell lung cancer (NSCLC) and is a potential target for treatment Source: Eur Respir J 2002; 20: Suppl. 38, 400s Year: 2002 New treatment options for nonsmall cell lung cancer and small cell lung cancer Source: Annual Congress 2006 - PG12 - Small cell lung cancer management Year: 2006 Major changes in men with non-small-cell lung cancer (NSCLC) in 10 years: The KBP-2000-CPHG and KBP-2010-CPHG cohorts Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013 Quality indicators in lung cancer care-review of resection rates in early stage NSCLC (non small cell lung cancer) at King’s Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018